Roivant Sciences (ROIV) Amortizatization of Intangibles (2024 - 2025)
Roivant Sciences' (ROIV) quarterly Amortizatization of Intangibles came in at $29.6 million in Q4 2025, down 45.48% YoY from $54.3 million in Q4 2024, and up 201.43% on a QoQ basis from $9.8 million in Q3 2025.
Roivant Sciences (ROIV) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends
Roivant Sciences (ROIV) has 2 years of Amortizatization of Intangibles data on file, last reported at $29.6 million in Q4 2025.
- Quarterly Amortizatization of Intangibles fell 45.48% year-over-year to $29.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $104.8 million (up 32.08% YoY) and the FY2025 annual result came in at $70.0 million, changed N/A from the prior year.
- Amortizatization of Intangibles climbed to $29.6 million in Q4 2025, from $9.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $54.3 million in Q4 2024 to a low of $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Roivant Sciences | 26.20 Bn | 26.20 Bn | 1.16 Mn | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.61 Mn |
| Dec 31, 2025 | 29.61 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Dec 31, 2024 | 54.30 Mn |
| Dec 31, 2024 | 54.30 Mn |
| Sep 30, 2024 | 25.04 Mn |
| Sep 30, 2024 | 25.04 Mn |